An alternative to the standard mixture model is proposed for modeling data containing cured elements or a cure fraction. This approach is based on the use of defective distributions to estimate the cure fraction as a function of the estimated parameters. In the literature there are just two of these distributions: the Gompertz and the inverse Gaussian. Here, we propose two new defective distributions: the Kumaraswamy Gompertz and Kumaraswamy inverse Gaussian distributions, extensions of the Gompertz and inverse Gaussian distributions under the Kumaraswamy family of distributions. We show in fact that if a distribution is defective, then its extension under the Kumaraswamy family is defective too. We consider maximum likelihood estimation of the extensions and check its finite sample performance. We use three real cancer data sets to show that the new defective distributions offer better fits than baseline distributions.

In this paper, we propose a defective model induced by a frailty term for modeling the proportion of cured. Unlike most of the cure rate models, defective models have advantage of modeling the cure rate without adding any extra parameter in model. The introduction of an unobserved heterogeneity among individuals has bring advantages for the estimated model. The influence of unobserved covariates is incorporated using a proportional hazard model. The frailty term assumed to follow a gamma distribution is introduced on the hazard rate to control the unobservable heterogeneity of the patients. We assume that the baseline distribution follows a Gompertz and inverse Gaussian defective distributions. Thus we propose and discuss two defective distributions: the defective gamma-Gompertz and gamma-inverse Gaussian regression models. Simulation studies are performed to verify the asymptotic properties of the maximum likelihood estimator. Lastly, in order to illustrate the proposed model, we present three applications in real data sets, in which one of them we are using for the first time, related to a study about breast cancer in the A.C.Camargo Cancer Center, São Paulo, Brazil.